Antithrombotic Therapy at the End of Life: The PEACE Study

Starting soon

Conditions studied: Palliative Care

In brief

"Antithrombotic Therapy at the End of Life: The PEACE Study" is a multicenter, non-profit, cross-sectional observational study. In the absence of shared guidelines, therapeutic decisions on antithrombotic drugs vary significantly according to healthcare professional training and national context, resulting in marked variability in prescribing practices. This study aims to describe the prevalence of antithrombotic prescriptions in patients referred to Palliative Care.

Key facts

Study ID

NCT07338071

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

410

Starts

2026-01-01

Expected to finish

2027-11-01

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (≥18 years) hospitalized and referred to Palliative Care (home-based or residential) at the discretion of the attending physician.
• Signed informed consent

You may not qualify if…

• none

Where it is running

• Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Roma, RM, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.